The role of real-world evidence in health technology assessment decision-making: what differences between RWE and randomised controlled trials (RCTs) are highlighted in HTA guidelines, and how do these differences impact the assessment of effectiveness and safety? A systematic literature review
Year: 2024
Type: review
Study design: Systematic Review
Abstract: This Systematic Literature Review (SLR) investigates the integration of Real-World Evidence (RWE) into Health Technology Assessment (HTA) processes to address the limitations of Randomized Controlled Trials (RCTs) in healthcare decision-making. The SLR examines methodological, data quality, and regulatory factors influencing RWE adoption across diverse healthcare systems. The findings reveal significant variability in HTA practices across countries, highlighting barriers such as inconsistent frameworks and limited interoperability. By synthesising evidence, this research underscores RWE’s potential to complement traditional evidence, improve patient access, and inform reimbursement decisions, supporting global efforts to optimise HTA methodologies and promote equitable healthcare policies.
Author: Lialina, Elena
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: green
OpenAlex ID: W7024512210
